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STUDIES IN HUMANS
Effect of two dosages of sodium chloride intake on the blood pressure
response to caffeinated coffee in humans in vivo
Anne C. Esselinka,b, Lisanne M. Brilb, Renee W. Langenhuijsenc, Albert Bilosb, Niels P. Riksena and
Gerard A. Rongena,b
aDepartment of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands; bDepartment of Pharmacology-
Toxicology, Radboud University Medical Center, Nijmegen, The Netherlands; cDepartment of Gastro-Enterology and Hepatology,
Dietetics and Intestinal Failure, Radboud University Medical Center, Nijmegen, the Netherlands
ABSTRACT
High sodium intake increases cardiovascular risk by increasing blood pressure. The intake of
coffee elevates blood pressure acutely. Preclinical evidence shows that this action of caffeine
is enhanced by high salt intake. We hypothesised that high sodium intake augments the
acute blood pressure response to coffee in humans. A randomised cross-over study (n¼ 15)
was performed comparing the effect of lower (6 g/d; LS) with higher (12 g/d; HS) sodium
chloride diet on blood pressure before and 2 h after regular coffee intake. Baseline blood
pressure was 115 ± 4/84 ± 2/68 ± 1 during LS and 121 ± 4/89 ± 2/69 ± 1mmHg during HS
(SBP/Mean Arterial Pressure (MAP)/DBP; mean ± SE, p< 0.05 for SBP). During LS, blood pres-
sure increased to 121 ± 4/91 ± 2/73 ± 1 (p< 0.05 for SBP, MAP, DBP versus baseline). HS did
not significantly affect the impact of coffee on blood pressure (p> 0.3 for SBP, DBP; p> 0.05
for MAP). Sodium intake does not relevantly modulate the impact of regular coffee consump-
tion on blood pressure.
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Introduction
Lifestyle has an important impact on cardiovascular
health. Smoking, inactivity and high caloric diet are
well-accepted risk factors for cardiovascular disease.
In addition, in population-based cohorts daily
sodium intake is associated with cardiovascular risk
(O’Donnell et al. 2014). Sodium intake is positively
correlated with blood pressure, an established deter-
minant of cardiovascular risk (He et al. 1998, 2013;
Intersalt Cooperative Research Group 1988; Sacks
et al. 2001; Obarzanek et al. 2003; Mente et al.
2014). Reduction in sodium intake has been associ-
ated with reduced cardiovascular events (Cook et al.
2007; Strazzullo et al. 2009; Aburto et al. 2013).
Thus, it seems likely that blood pressure, at least in
part, mediates the association between sodium take
and cardiovascular events. The World Health
Organisation advices a daily intake of 2 g of sodium
(87mmol Naþ) per day. Globally, the actual salt
intake is much higher and may be responsible for
1.65 million deaths from cardiovascular causes annu-
ally (Mozaffarian et al. 2014).
After at least 24 h of caffeine abstinence, caffeine-
containing beverages acutely raise blood pressure.
This effect is mediated, at least in part, by antagonism
of the vasodilator actions of endogenous adenosine
(Smits et al. 1987; van Dusseldorp et al. 1989). In con-
trast to salt intake, the relation between the use of caf-
feine-containing beverages and cardiovascular events
is much more controversial. While most retrospective
observational studies report a positive association
between patient-reported coffee use and cardiovascu-
lar events, prospective studies do not confirm this
relationship (Riksen et al. 2009; Guessous et al. 2014).
Several reasons for this ambiguity have been sug-
gested. Prospective studies may underestimate the
potential impact of the transient and acute effects of
coffee intake as triggers of a cardiovascular event,
such as adrenal release of epinephrine, increase in
blood pressure and increased susceptibility from
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ischaemia and reperfusion (Riksen et al. 2009, 2011).
Furthermore, population-based observational studies
have largely neglected potential interactions between
lifestyle factors such as salt and coffee intake.
Preclinical evidence in animals has indicated that
high sodium intake augments the vasodilator actions of
adenosine (Liclican et al. 2005; Dobrowolski et al. 2007;
Nayeem et al. 2010, 2011). In addition, some older evi-
dence suggests that high sodium intake increases
endogenous extracellular adenosine formation (Siragy
and Linden 1996). Further, inhibition of the adenosine
A2A receptor has been shown to cause hypertension
(Poucher et al. 1995; Liclican et al. 2009; Carroll 2012).
Thus, the pressor effect of high salt intake may be
counteracted by increased adenosine formation and
subsequent adenosine receptor-mediated vasodilation.
Since caffeine antagonises the vasodilator action of
adenosine, we hypothesised that the acute pressor
effect of caffeinated coffee is potentiated by high salt
intake. According to this hypothesis, the impact of
coffee consumption on cardiovascular risk should be
higher in those who use more salt in their diet. If
true, this interaction between salt and coffee intake
on blood pressure should be taken into account in
population-based observational studies on the rela-
tion between coffee intake and cardiovascular disease.
Because of this potential high societal impact, we
decided to explore the modulating effect of salt
intake on the coffee-induced rise in blood pressure
in humans.
Materials and methods
Study population
This study was approved by the institutional ethics
review board (CMO Arnhem-Nijmegen; registration
number 2012/113) and was performed according to
the declaration of Helsinki.
Fifteen healthy volunteers (eight females) were
recruited at the university campus. After informed
consent, all participants were screened for in- and
exclusion criteria. Inclusion criteria were: unremark-
able medical history, 18 years of age and signed
informed consent. Exclusion criteria were: current
medication or recreational drug use (except use of
oral contraceptives), a body mass index >25 kg/m2,
hypertension (defined as systolic blood pressure
>140mmHg and/or diastolic blood pressure
>90mmHg), a difference in systolic blood pressure of
10mmHg between two arms, intake of >2 alcohol
consumptions per day, cardiovascular abnormalities
detected by routine history and physical examination.
Study design
This study was performed in a university hospital
(Radboudumc) and designed as a cross-over study.
In all participating volunteers, a three-day food diary
was obtained. Each food diary contained one week-
end day. Based on this diary, a dietician (RL)
extracted two unique individual diets per participant:
a diet relatively lower (6 g/24h) and higher (12 g/24h)
in sodium chloride. We chose for a 6 g/24 h diet
because compliance to the diet was extremely import-
ant and we presumed that a lower <5 g/24 h sodium
chloride diet (as is advised by the World Health
Organisation (WHO)) would be difficult to follow in
daily practice for most participants. Subsequently, all
volunteers were randomly assigned to “group A” or
“group B”. Group A started on a lower sodium chlor-
ide diet for five consecutive days followed by a test
day and a wash-out period of at least 4 days, during
which the volunteer used his or her regular diet.
Thereafter, a higher sodium chloride diet was taken
for 5 days, finished by a test day. Group B followed
the protocol in reversed order (higher salt intake
first). During the final 24 h of each period of regulated
sodium intake the participants abstained from nico-
tine, alcohol and caffeine containing products, to
exclude these as possible confounders. The last 2 h
before the experiment on the test day they abstained
from all food and drinks, except water. Physical activ-
ity was not recorded, but we asked participants to
stick to their normal lifestyle during the entire study.
Two procedures were performed to verify compliance
to the diet. At the end of each period of regulated
sodium intake, all participants collected a 24 h urine
sample, which was analysed for volume, sodium and
creatinine excretion to check for compliance to
sodium intake. Furthermore, at arrival on each test
day venous blood was sampled to determine the base-
line plasma caffeine concentration to check appropri-
ate caffeine abstinence.
After emptying the bladder, the baseline blood
pressure was recorded in sitting position on the non-
dominant arm at 5min intervals for 15min with an
oscillometric automatic blood pressure device
(Dinamap, 1846 SX; Critikon, Portanje Electronica
BV, Utrecht, The Netherlands). Subsequently 350ml
of regular black coffee was taken orally within
15min. After this, blood pressure recording was
resumed at 5-min intervals for another 2 h. Two
hours after coffee ingestion, another 5ml venous
blood sample was obtained to measure the plasma
caffeine concentration.
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Coffee preparation
Before each coffee administration, coffee was freshly
prepared according to a standardised procedure using
the same coffee brewer; 350ml water was dripped on
24 g of ground coffee (Douwe Egberts Gold, Douwe
Egberts, Utrecht, The Netherlands). This is a mixture of
beans of the plants Coffea Arabica and Coffea Robusta.
Analytical procedures
Determination of the plasma caffeine concentration
was done by using a reversed-phase high-performance
liquid chromatography (HPLC) method with UV-
detection set at 273mm according to Schreiber-
Deturmeny and Brugerolle (1996). Urinary sodium was
measured using an ion-selective electrode (ISE) method
and creatinine was measured using an enzymatic col-
orimetric method. Both measurements were performed
using an automized platform (Architect C16000,
Abbott Diagnostics Nederland BV, Hoofddorp, the
Netherlands).
Sample size calculation
Based on a previous study (Smits et al. 1983, 1985a)
we anticipated that the intake of two cups of caffeine
containing coffee prepared as in this study increased
systolic blood pressure by 5 ± 5 (SD), mean arterial
pressure by 9 ± 5 and diastolic blood pressure by
11 ± 7mmHg. We assumed a between-test correlation
in blood pressure response of 0.8. Based on these
assumptions we calculated a group size of 10 volun-
teers to allow the detection of a 4mmHg difference in
blood pressure response to coffee between lower and
higher salt intake conditions for systolic and mean
arterial blood pressure and 15 volunteers for diastolic
blood pressure (power 0.9; two-sided alpha of 0.05).
Statistical analysis
Blood pressure and heart rate measurements during
the last 10min before coffee intake were averaged and
taken as baseline. After ingestion of coffee, blood
pressure recordings were averaged for each subsequent
30min. Results are given as mean ± SE unless indi-
cated otherwise. The effect of salt, coffee and the
interaction between salt and coffee intake on blood
pressure (primary endpoint) was analysed using a
repeated measures ANOVA with sodium intake and
time after coffee intake as within subject factors.
Baseline sodium excretion and plasma caffeine con-
centrations were compared between the two study
days using paired t-tests. Two-sided p values <0.05
were considered to indicate statistical significance.
Results
Compliance to protocol
Two of the 15 participants were excluded for further
analysis: one because of presumed violation of the diet
instructions (on both days the same amount of urin-
ary sodium) and one subject was withdrawn from the
study due to an intercurrent illness with fever.
Another participant originally allocated to group B,
appeared to have switched the high and low salt diets
as concluded from his urinary sodium excretion. He
was reallocated afterwards to group A according to
these urinary sodium results. Finally, group A and B
contained 6 and 7 subjects respectively. Baseline char-
acteristics of the remaining 13 volunteers are pre-
sented in Table 1. Relevant laboratory results for all
13 participants are presented in Table 2. In general,
caffeine concentration and sodium excretion were in
line with what was expected from the intake according
to the protocol.
Blood pressure and heart rate
Courses in blood pressure and heart rate did not sig-
nificantly differ between group A and B (data not
shown). Results are presented for both groups com-
bined (Figure 1). Systolic blood pressure was signifi-
cantly higher at the end of higher salt intake as
compared with lower salt intake (121 ± 4mmHg vs.
115 ± 4mmHg; p< 0.05). Diastolic blood pressure,
mean arterial pressure and heart rate were not signifi-
cantly affected by salt intake, although mean arterial
pressure tended to be increased (p< 0.1; see Figure 1).
All three blood pressure parameters significantly
increased and heart rate significantly decreased after
Table 1. Baseline characteristics of volunteers (n¼ 13).
Characteristic
Male/Female (n) 7/6
Age (years) 24 ± 8
BMI 22 ± 2
Current smokers 2
Daily alcohol consumption
<1 beverage 4
1 beverage 5
2 beverages 4
SBP (mmHg) 120 ± 9
DBP (mmHg) 68 ± 10
MAP (mmHg) 85 ± 10
Heart rate (bpm) 64 ± 7
bpm: beats per minute; DBP: diastolic blood pressure; SBP: systolic blood
pressure; MAP: mean arterial pressure.
Expressed as mean ± SD.
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coffee intake (p< 0.001 for all four parameters).
However, salt intake did not significantly modulate
the course in heart rate and blood pressure after cof-
fee intake (interaction: p> 0.3 for heart rate, systolic
and diastolic blood pressure; p> 0.05 for mean arterial
pressure, see Figure 1).
Discussion
Based on preclinical findings, we hypothesised that
salt intake modulates the blood pressure response to
acute caffeinated coffee exposure. However, in our
study this potential interaction was not confirmed in
humans in vivo. This observation does not support
our hypothesis that adenosine (A2)-receptor-induced
vasodilation mitigates the salt-associated increase in
blood pressure as based on previously reported studies
in small rodents. Therefore, our results do not support
the need to take salt intake into account when
investigating the cardiovascular effect of coffee intake
in epidemiological studies.
As is known from earlier studies, a higher salt
intake increased SBP (Intersalt Cooperative Research
Group 1988; Sacks et al. 2001). The increase by
140mmol Naþ/day from lower to higher salt intake in
our study raised systolic blood pressure by approxi-
mately 6mmHg. So even while the lower sodium
chloride diet (6 g/24 h) intake was still higher than is
advised by the WHO we found a significant difference
in SBP between the two dosages of salt. This observa-
tion fits well with an observational study in 100.000
patients by Mente et al. in which an increase in
sodium excretion from 1.7 g/d to 4.9 g/d (74 to
213mmol/d) raised systolic blood pressure with
4.3mmHg (Mente et al. 2014). Thus, the observed
blood pressure effect of a short term increase in salt
intake in our relatively small study population equals
the observation in a very large cohort of chronic salt
exposure. From this, we conclude that the 5-day
Table 2. Laboratory values (expressed as mean ± SD).
Lower salt Higher salt p Value
Plasma caffeine (mmol/ml) baseline 0.2 ± 0.2 0.2 ± 0.4 0.665
Plasma caffeine (mmol/ml) 2 h after coffee intake 6.6 ± 1.8 6.4 ± 1.7 0.420
Urinary Naþ excretion (mmol/24 h) 75 ± 39 214 ± 72 <0.001
Urinary creatinine excretion (mmol/24 h) 13 ± 4 14 ± 3 <0.05
Figure 1. Blood pressure and heart rate after low salt (LS) and high salt (HS) diet, at baseline and every 30min after coffee drink-
ing (grey area). SBP: systolic blood pressure; DBP: diastolic blood pressure; MAP: mean arterial pressure; HR: heart rate; NS: Not
Significant. Significant increase of BP and decrease of HR after coffee intake (p< 0.001).
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duration of regulated sodium intake was sufficient to
achieve a hemodynamic steady state. Our study was
not designed to quantify the blood pressure response
to coffee perse, as we did not include a placebo arm.
The average increase in SBP and DBP (4.3% and
8.2%) however, was the same as in a previous study
with an appropriate control group, in which SBP and
DBP rose 4.4% and 11.4%, respectively, after drinking
the same coffee preparation as in our study (350ml
water and 24 g coffee; Smits et al. 1985a). As con-
firmed by the plasma caffeine concentrations, the caf-
feine intake was highly standardised in our study.
Smits et al. also described the potential confounding
effect of a genetically determined slow metabolism of
caffeine, which is important because an optimal blood
pressure increase in response to caffeine will occur
only after sufficient caffeine abstinence (Smits et al.
1985b). In our study, the potential impact of inter-
individual variation in caffeine elimination appears
neglectable since on arrival on both the test days caf-
feine plasma levels were low and equivalent, indicating
sufficient caffeine abstinence. Thus, in our study all
participants were exposed to a similar amount of cof-
fee and caffeine on both test days and the blood pres-
sure course after coffee intake in the present study fits
with previous observations with an appropriate con-
trol group. There are some limitations to our experi-
ment. Dietary intake apart from sodium intake during
the intervention periods was not assessed. Therefore,
we cannot exclude that consumption of other foods or
food components (for example high potassium intake)
may have interfered with the results. And although
smoking and alcohol consumption was explicitly pro-
hibited 24 h before the experiment, we were not able
to verify whether abstinence took place. However,
only 2 of 13 participants were regular smokers and
alcohol consumption varied between volunteers from
0 to 2 beverages a day, so we assume that the possible
risk of confounding the outcome is low. And although
physical activity level was not objectivated during the
intervention and this could have possibly influenced
our data, all participants were fit adults (mean age
24 years). Also each participant served as its own con-
trol in this cross-over design further limiting the pos-
sible impact of variation in fitness.
Therefore, we conclude that the internal validity of
our study in terms of salt and coffee exposure as well
as external validity in terms of blood pressure response
to salt and coffee were excellent. An explanation for
our negative results with respect to the interaction
between coffee and salt on blood pressure could be
that the effect of sodium on adenosine formation and
adenosine receptor stimulation that has been observed
in murine models does not occur in humans. Another
potential explanation is that caffeine is also believed to
have a diuretic effect. A recent meta-analysis however
revealed that the proposed diuretic action of caffeine is
very modest and unlikely to interfere with the blood
pressure response to coffee (Zhang et al. 2015).
In conclusion, the present study shows that high
sodium intake does not relevantly augment the blood
pressure response to two cups of coffee.
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